{"title":"Pembrolizumab","summary":"Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, and cervical cancer.[3][5][6] It is given by slow injection into a vein.[6]","image":"Pembrolizumab_5DK3.png.webp"}